- Aspen Pharmacare Holdings Ltd Manufacturing Day and site visit 2023 SESSION 3 TranscriptNov 29, 2023
- Aspen Pharmacare Holdings Ltd Manufacturing Day and site visit 2023 Session 1 TranscriptNov 29, 2023
- Full Year 2023 Aspen Pharmacare Holdings Ltd Earnings Call TranscriptAug 31, 2023R172.2 (+0.50%)Earnings
- Half Year 2023 Aspen Pharmacare Holdings Ltd Earnings Call TranscriptMar 02, 2023R168.74 (+4.97%)Earnings
- Full Year 2022 Aspen Pharmacare Holdings Ltd Earnings Call TranscriptSep 01, 2022R156.89 (+6.37%)Earnings
- Half Year 2022 Aspen Pharmacare Holdings Ltd Earnings Call TranscriptMar 10, 2022R173.93 (-5.25%)Earnings
- Aspen Pharmacare Holdings Ltd Aspen Confirms Non-Binding Term Sheet on Manufacture And Sale of an Aspen Branded COVID-19 vaccine Throughout Africa Call TranscriptNov 30, 2021
- Full Year 2021 Aspen Pharmacare Holdings Ltd Earnings Call TranscriptSep 02, 2021R199.9 (+4.93%)Earnings
- Half Year 2021 Aspen Pharmacare Holdings Ltd Earnings Call TranscriptMar 12, 2021R149.95 (-0.70%)Earnings
- Aspen Pharmacare Holdings Ltd Virtual Investor Day TranscriptDec 11, 2020
- Full Year 2020 Aspen Pharmacare Holdings Ltd Earnings Call TranscriptSep 10, 2020R131.54 (-5.67%)Earnings
- Half Year 2020 Aspen Pharmacare Holdings Ltd Earnings Presentation TranscriptMar 06, 2020
- Full Year 2019 Aspen Pharmacare Holdings Ltd Earnings Presentation TranscriptSep 12, 2019
- Half Year 2019 Aspen Pharmacare Holdings Ltd Earnings Presentation TranscriptMar 08, 2019
Aspen Pharmacare Holdings Ltd Virtual Investor Day Transcript
Good afternoon, everybody, and welcome to the Aspen Investor Day. It's our presentation here. We hope to take you through some of our objectives going forward.
But if I would like to start, it's maybe just cover a little bit of this year because it's been a very interesting year for us, I'd say probably best characterized by saying it's been both a rewarding and an incredibly stressful year, rewarding not only on the financial front in that we've got a reshaped base and a very clear strategy that we will articulate with you -- to you over the next hour or so. We've also had growth, as you know, of 9% in our financial year 2020 in spite of COVID. And we've had a -- we've managed to strengthen our balance sheet significantly.
It's -- we've not only, in this period, in terms of rewards, received dividends. And those dividends are really in the form of our -- that our new strategic direction has delivered for us. We have made, although a small company in global pharma terms, a very large
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)